| Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453, 2016 | 1558 | 2016 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1002 | 2019 |
| Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer Nature Medicine, 2016 | 688 | 2016 |
| Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer Cell 173, 1770–1782, 2018 | 477 | 2018 |
| Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress MD Nyquist, A Corella, I Coleman, N De Sarkar, A Kaipainen, G Ha, ... Cell reports 31 (8), 2020 | 176 | 2020 |
| Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer SC Baca, DY Takeda, JH Seo, J Hwang, SY Ku, R Arafeh, T Arnoff, ... Nature communications 12 (1), 1979, 2021 | 87 | 2021 |
| Concordance of DNA repair gene mutations in paired primary prostate cancer samples and metastatic tissue or cell-free DNA MT Schweizer, S Sivakumar, H Tukachinsky, I Coleman, N De Sarkar, ... JAMA oncology 7 (9), 1378-1382, 2021 | 52 | 2021 |
| A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers N De Sarkar, R Roy, JK Mitra, S Ghose, A Chakraborty, RR Paul, ... PloS one 9 (8), e104839, 2014 | 44 | 2014 |
| Regulation of CEACAM5 and therapeutic efficacy of an anti-CEACAM5–SN38 antibody–drug conjugate in neuroendocrine prostate cancer DC DeLucia, TM Cardillo, L Ang, MP Labrecque, A Zhang, JE Hopkins, ... Clinical Cancer Research 27 (3), 759-774, 2021 | 43 | 2021 |
| Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy BR Winters, N De Sarkar, S Arora, H Bolouri, S Jana, F Vakar-Lopez, ... JCI insight 4 (13), 2019 | 38 | 2019 |
| MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues R Roy, R Singh, E Chattopadhyay, A Ray, N De Sarkar, R Aich, RR Paul, ... Gene 593 (1), 58-63, 2016 | 38 | 2016 |
| A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA AL Doebley, M Ko, H Liao, AE Cruikshank, K Santos, C Kikawa, JB Hiatt, ... Nature Communications 13 (1), 7475, 2022 | 37 | 2022 |
| Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer E Chattopadhyay, R Singh, A Ray, R Roy, N De Sarkar, RR Paul, M Pal, ... Scientific Reports 6 (1), 32735, 2016 | 36 | 2016 |
| Genetic variations at microRNA and processing genes and risk of oral cancer R Roy, N De Sarkar, S Ghose, RR Paul, M Pal, C Bhattacharya, ... Tumor Biology 35, 3409-3414, 2014 | 33 | 2014 |
| Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth MD Nyquist, LS Ang, A Corella, IM Coleman, MP Meers, AJ Christiani, ... The Journal of clinical investigation 131 (10), 2021 | 31 | 2021 |
| Effects of arsenic toxicity on germination, seedling growth and peroxidase activity in Cicer arietinum S Bhattacharya, N De Sarkar, P Banerjee, S Banerjee, S Mukherjee, ... Int J Agric Food Sci 2 (4), 131-137, 2012 | 29 | 2012 |
| Association between risk of oral precancer and genetic variations in microRNA and related processing genes R Roy, N De Sarkar, S Ghose, RR Paul, A Ray, I Mukhopadhyay, B Roy Journal of biomedical science 21, 1-7, 2014 | 24 | 2014 |
| Clinical determinants for successful circulating tumor DNA analysis in prostate cancer MT Schweizer, R Gulati, M Beightol, EQ Konnick, HH Cheng, N Klemfuss, ... The Prostate 79 (7), 701-708, 2019 | 22 | 2019 |
| Targeted gene sequencing of gallbladder carcinoma identifies high-impact somatic and rare germline mutations S Yadav, N De Sarkar, N Kumari, N Krishnani, A Kumar, B Mittal Cancer Genomics & Proteomics 14 (6), 495-506, 2017 | 22 | 2017 |
| Genome-wide mitochondrial DNA sequence variations and lower expression of OXPHOS genes predict mitochondrial dysfunction in oral cancer tissue E Chattopadhyay, N De Sarkar, R Singh, A Ray, R Roy, RR Paul, M Pal, ... Tumor Biology 37, 11861-11871, 2016 | 17 | 2016 |
Ilsa ColemanResearch Scientist, Fred Hutchinson Cancer Research CenterVerified email at fhcrc.org
